EUVIMEDOdkrijte EUVIMED
Crossref

Scutellarin Alleviates Hepatic Steatosis by Autophagy‐Mediated NCoR1 / PPARα ‐Driven Fatty Acid β‐Oxidation and Enhancing Peroxisome Biogenesis

Jianmei Zheng, Lu Cheng, Yingmin Wei, Mingshi Ren, Lei Wang, Jingwen Wang, Wuliu Zhou, Hui Huang, Feihua Wu

Phytotherapy Research · 2026-07 · 40 (7) · 4278-4293

DOI: 10.1002/ptr.70367 ↗

At a glance

Journal article in Phytotherapy Research, published online on 2026-05-05. Written by Jianmei Zheng and 8 co-authors. Institution: Department of Pharmacology of Chinese Materia Medica, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, China. Major MEDLINE topics: PPAR alpha, Apigenin, Autophagy, Peroxisomes. 46 references. Funded by: Postgraduate Research & Practice Innovation Program of Jiangsu Province.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Metabolic dysfunction‐associated steatotic liver disease (MASLD) is a prevalent chronic liver disorder with limited treatment and manifests as hepatic lipid accumulation. The reduction of nuclear receptor corepressor 1 (NCoR1) activates the nuclear receptor PPARα, which plays a crucial role in alleviating lipid accumulation. We found that Scutellarin (Scu) regulated autophagy‐mediated NCoR1/PPARα to enhance fatty acid (FA) β‐oxidation and peroxisome production, thereby alleviating the lipid accumulation of MASLD. We used palmitic acid (PA)‐treated human hepatocellular carcinoma (HepG2) and alpha mouse liver 12 (AML12) cells, as well as high‐fat diet‐fed C57BL/6J mice to evaluate the protective effect of Scu on MASLD. Scu reduced the levels of total cholesterol, triglycerides, and lipid droplets, whereas it dose‐dependently increased the levels of β‐hydroxybutyrate. In addition, Scu increased mRNA and protein expression of PPARα and promoted the transcriptional activity of FA β‐oxidation‐related target genes. In vitro, inhibition of PPARα with small interfering RNA (siRNA) abolished the activation of FA β‐oxidation by Scu. Cellular thermal shift assay and drug affinity responsive target stability demonstrated that Scu did not interact directly with PPARα. Moreover, Scu increased the protein expression of 70‐kDa peroxisomal membrane protein and the mRNA expression of peroxisome biogenesis‐related genes. These effects were reversed by PPARα‐siRNA. Scu improved the impaired autophagy while reducing the mRNA and protein expression of NCoR1. Notably, Scu reduced the colocalization of NCoR1 with PPARα and increased its colocalization with the autophagosome GABARAP. 3‐MA, an autophagy inhibitor, attenuated Scu‐mediated protective effects by FA β‐oxidation and peroxisome biogenesis both in vitro and in vivo. In summary, Scu reduces lipid accumulation by improving the impaired autophagy, decreasing NCoR1 expression to activate PPARα, thereby simultaneously enhancing FA β‐oxidation and peroxisome biogenesis, ultimately ameliorating hepatic steatosis.

Subjects

MeSH terms (MEDLINE)

PPAR alphaApigeninAutophagyPeroxisomesFatty AcidsNuclear Receptor Co-Repressor 1Fatty LiverGlucuronatesAnimalsHumansMiceMice, Inbred C57BLOxidation-ReductionHep G2 CellsMaleLipid MetabolismDiet, High-Fat

Author keywords

MASLDNCoR1PPARαScutellarinfatty acid β‐oxidationperoxisome

Substances

PPAR alphaApigeninscutellarinFatty AcidsNuclear Receptor Co-Repressor 1GlucuronatesNcor1 protein, mousePpara protein, mouse

Authors and institutions

  • Department of Pharmacology of Chinese Materia Medica, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, China.
  • National R&D Center for Chinese Herbal Medicine Processing Department of Food Quality and Safety, College of Engineering, China Pharmaceutical University, Nanjing, China.

Funding

  • Postgraduate Research & Practice Innovation Program of Jiangsu Province

Cite

APA

Zheng, J., Cheng, L., Wei, Y., Ren, M., Wang, L., Wang, J., Zhou, W., Huang, H., & Wu, F. (2026). Scutellarin Alleviates Hepatic Steatosis by Autophagy‐Mediated NCoR1 / PPARα ‐Driven Fatty Acid β‐Oxidation and Enhancing Peroxisome Biogenesis. Phytotherapy Research, 40(7), 4278-4293. https://doi.org/10.1002/ptr.70367

Vancouver

Zheng J, Cheng L, Wei Y, Ren M, Wang L, Wang J, et al. Scutellarin Alleviates Hepatic Steatosis by Autophagy‐Mediated NCoR1 / PPARα ‐Driven Fatty Acid β‐Oxidation and Enhancing Peroxisome Biogenesis. Phytotherapy Research. 2026;40(7):4278-4293. doi:10.1002/ptr.70367

BibTeX
@article{Zheng2026,
  author = {Zheng, Jianmei and Cheng, Lu and Wei, Yingmin and Ren, Mingshi and Wang, Lei and Wang, Jingwen and Zhou, Wuliu and Huang, Hui and Wu, Feihua},
  title = {Scutellarin Alleviates Hepatic Steatosis by Autophagy‐Mediated NCoR1 / PPARα ‐Driven Fatty Acid β‐Oxidation and Enhancing Peroxisome Biogenesis},
  journal = {Phytotherapy Research},
  year = {2026},
  volume = {40},
  number = {7},
  pages = {4278--4293},
  doi = {10.1002/ptr.70367}
}
Start for free →